Polaris Group (TPE:6550)
Taiwan · Delayed Price · Currency is TWD 11.55
+0.55 (5.00%)
Aug 26, 2026, 1:30 PM CST
Polaris Group Market Cap
Polaris Group has a market cap or net worth of 9.46 billion as of August 25, 2026. Its market cap has decreased by -71.58% in one year.
Market Cap
9.46B
Enterprise Value
10.68B
Revenue
69.27M
Ranking
n/a
PE Ratio
n/a
Stock Price
11.55
ChartMarket Cap Chart
Since February 15, 2016, Polaris Group's market cap has decreased from 46.46B to 9.46B, a decrease of -79.64%. That is a compound annual growth rate of -14.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 25, 2026 | 9.46B | -60.53% |
| Dec 31, 2025 | 23.96B | -29.66% |
| Dec 31, 2024 | 34.06B | -39.39% |
| Dec 29, 2023 | 56.21B | -14.57% |
| Dec 30, 2022 | 65.79B | 24.20% |
| Dec 30, 2021 | 52.97B | 373.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ACRO Biomedical | 14.99B |
| Gongwin Biopharm Holdings | 13.45B |
| Lumosa Therapeutics | 12.98B |
| TCM Biotech International | 10.36B |
| AP Biosciences | 9.70B |
| Tanvex BioPharma | 9.61B |
| PharmaEngine | 8.51B |
| Locus Cell | 7.74B |